Back to top
more

Agilent Technologies (A)

(Delayed Data from NYSE)

$123.75 USD

123.75
1,486,050

+0.36 (0.29%)

Updated Sep 29, 2025 04:00 PM ET

After-Market: $123.78 +0.03 (0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (150 out of 245)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce.

Zacks Equity Research

Company News for May 26, 2022

by Zacks Equity Research

Companies In The News Are: DKS, A, DY, JWN.

Zacks Equity Research

Agilent (A) Q2 Earnings Surpass Estimates, Revenues Rise Y/Y

by Zacks Equity Research

Agilent's (A) results for the fiscal second quarter reflect strong momentum in the pharma and chemical & energy market.

Zacks Equity Research

Agilent Technologies (A) Q2 Earnings Beat Estimates

by Zacks Equity Research

Agilent (A) delivered earnings and revenue surprises of 1.80% and 0.33%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

What's in the Cards for Agilent Technologies' (A) Q2 Earnings?

by Zacks Equity Research

Agilent Technologies' (A) fiscal second-quarter results are expected to reflect portfolio strength and momentum across all segments.

Zacks Equity Research

Agilent Technologies (A) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Cognex Corporation (CGNX) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research

Cognex Corporation (CGNX) delivered earnings and revenue surprises of 7.69% and 2.33%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Wolfspeed (WOLF) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

Wolfspeed (WOLF) delivered earnings and revenue surprises of 14.29% and 1.28%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Ametek (AME) Tops Q1 Earnings Estimates

by Zacks Equity Research

Ametek (AME) delivered earnings and revenue surprises of 4.72% and 0.17%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

National Instruments (NATI) Misses Q1 Earnings and Revenue Estimates

by Zacks Equity Research

National Instruments (NATI) delivered earnings and revenue surprises of -6.82% and 4.69%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Zacks Industry Outlook Highlights Agilent Technologies, AMETEK, Fortive, and Cognex

by Zacks Equity Research

Agilent Technologies, AMETEK, Fortive, and Cognex Zacks Industry Outlook article.

Shilpa Mete headshot

4 Testing Equipment Stocks to Escape a Challenging Industry

by Shilpa Mete

Coronavirus--led disruptions are hurting the Zacks Electronics - Testing Equipment industry. However, industry participants like A, AME, FTV and CGNX are set to gain from 5G prospects.

Zacks Equity Research

Agilent (A) Boosts PD-L1 IHC 28-8 pharmDX Use in European Union

by Zacks Equity Research

Agilent Technologies (A) boosts its presence in the companion diagnostics market by expanding the use of PD-L1 IHC 28-8 pharmDx assay for esophageal squamous cell carcinoma treatment in the EU.

Zacks Equity Research

Agilent (A) Up 6.5% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point

by Zacks Equity Research

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

Zacks Equity Research

New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point

by Zacks Equity Research

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

Zacks Equity Research

Down 5.6% in 4 Weeks, Here's Why Agilent (A) Looks Ripe for a Turnaround

by Zacks Equity Research

Agilent (A) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Zacks Equity Research

Agilent (A) Q1 Earnings & Revenues Beat Estimates, Rise Y/Y

by Zacks Equity Research

Agilent's (A) fiscal first-quarter results benefit from solid momentum across all operating segments. Further, strong growth in the pharma market remains a tailwind.

Zacks Equity Research

Agilent Technologies (A) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Agilent (A) delivered earnings and revenue surprises of 3.42% and 1.30%, respectively, for the quarter ended January 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Agilent (A) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

Agilent's (A) fiscal first-quarter results are expected to reflect strength across LSAG, ACG and DGG segments.

Zacks Equity Research

NVIDIA (NVDA) Q4 Earnings Beat Estimates, Revenues Surge Y/Y

by Zacks Equity Research

NVIDIA's (NVDA) fourth-quarter fiscal 2022 results reflect benefits of higher demand for chips used in data centers and gaming consoles amid the work-and-learn-at-home and gaming waves.

Zacks Equity Research

Cisco's (CSCO) Q2 Earnings Top Estimates, Revenues Up Y/Y

by Zacks Equity Research

Cisco's (CSCO) fiscal second-quarter results reflect strength across the customer markets and revenue growth in all geographies.

Zacks Equity Research

The Trade Desk (TTD) Q4 Earnings and Revenues Top Estimates

by Zacks Equity Research

The Trade Desk's (TTD) fourth-quarter results reflect gains from solid customer retention and a growing partner ecosystem.

Zacks Equity Research

Fastly (FSLY) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Fastly's (FSLY) fourth-quarter 2021 revenues improve from the addition of new customers and the Computer@edge platform.

Zacks Equity Research

Shopify (SHOP) Q4 Earnings Beat Estimates, Revenues Up Y/Y

by Zacks Equity Research

Shopify's (SHOP) fourth-quarter 2021 results benefit from the addition of new merchants.

Zacks Equity Research

Ziff Davis (ZD) Earnings and Revenues Improve Y/Y in Q4

by Zacks Equity Research

Ziff Davis (ZD) fourth-quarter 2021 results reflect growth in Advertising revenues driven by health and wellness properties.